Viveve Medical, Inc. (VIVE)
VIVE Stock Price Chart
Explore Viveve Medical, Inc. interactive price chart. Choose custom timeframes to analyze VIVE price movements and trends.
VIVE Company Profile
Discover essential business fundamentals and corporate details for Viveve Medical, Inc. (VIVE) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
3 May 2010
Employees
47.00
Website
https://www.viveve.comCEO
Martin Kerber
Description
Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
VIVE Financial Timeline
Browse a chronological timeline of Viveve Medical, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 3 Oct 2024
Earnings released on 23 Sept 2024
Earnings released on 27 Jun 2024
Earnings released on 12 Feb 2024
Earnings released on 27 Nov 2023
Earnings released on 29 Sept 2023
Earnings released on 26 Jun 2023
Earnings released on 16 Mar 2023
Earnings released on 10 Nov 2022
EPS came in at -$0.59 surpassing the estimated -$0.66 by +10.61%, while revenue for the quarter reached $1.68M .
Earnings released on 11 Aug 2022
EPS came in at -$0.67 matching the estimated -$0.67, while revenue for the quarter reached $1.80M .
Earnings released on 12 May 2022
EPS came in at -$0.67 matching the estimated -$0.67, while revenue for the quarter reached $1.64M .
Earnings released on 17 Mar 2022
EPS came in at -$0.72 falling short of the estimated -$0.59 by -22.03%, while revenue for the quarter reached $1.71M , beating expectations by +0.35%.
Earnings released on 11 Nov 2021
EPS came in at -$0.67 falling short of the estimated -$0.61 by -9.84%, while revenue for the quarter reached $1.62M .
Earnings released on 12 Aug 2021
EPS came in at -$0.49 surpassing the estimated -$0.65 by +24.62%, while revenue for the quarter reached $1.65M , beating expectations by +8.82%.
Earnings released on 13 May 2021
EPS came in at -$0.80 falling short of the estimated -$0.51 by -56.86%, while revenue for the quarter reached $1.45M , beating expectations by +40.50%.
Earnings released on 18 Mar 2021
EPS came in at -$1.85 surpassing the estimated -$2.59 by +28.57%, while revenue for the quarter reached $1.95M .
Stock split effective on 2 Dec 2020
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Nov 2020
EPS came in at -$2.60 falling short of the estimated -$0.53 by -390.57%, while revenue for the quarter reached $1.52M , missing expectations by -26.39%.
VIVE Stock Performance
Access detailed VIVE performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.